Mankind Pharma Ltd Quarterly Result

Mankind Pharma Ltd Quarterly Result

Image

Mankind Pharma Ltd

NSE: MANKIND

Net Profit - Last Quarter

₹ 413.88 Cr.

Last updated on: May 12, 2026

Mankind Pharma Ltd Quarterly Results Key Highlights

  • The revenue of Mankind Pharma Ltd for the Dec '25 is ₹ 3643 crore as compare to the Sep '25 revenue of ₹ 3791 crore.
  • This represent the decline of -3.91% The ebitda of Mankind Pharma Ltd for the Dec '25 is ₹ 888.8 crore as compare to the Sep '25 ebitda of ₹ 1015 crore.
  • This represent the decline of -12.48% The net profit of Mankind Pharma Ltd for the Dec '25 is ₹ 413.88 crore as compare to the Sep '25 net profit of ₹ 520.18 crore.
  • This represent the decline of -20.44%.

Mankind Pharma Ltd Quarterly Results Analysis

Market Price of Mankind Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Mankind Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 May 20262469.25
08 May 20262427.15
07 May 20262375.4
06 May 20262361.9
05 May 20262320.65
04 May 20262260.6
30 Apr 20262246.55
29 Apr 20262254.6
28 Apr 20262269.95
27 Apr 20262266

Historical Revenue of Mankind Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Mankind Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Mankind Pharma Ltd

No data available

* All values are in crore

Mankind Pharma Ltd News Hub

Mankind Pharma allots 9000 equity shares under ESOP

Mankind Pharma has allotted 9000 equity shares under ESOP on 14 August 2024. Consequent to the afore

Read more

14 Aug 24

Mankind Pharma Ltd gains for fifth session

Mankind Pharma Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 2150.3, u

Read more

12 Aug 24

Mankind Pharma Ltd soars 1.03%

Mankind Pharma Ltd is up for a third straight session in a row. The stock is quoting at Rs 2079.3, u

Read more

08 Aug 24

Mankind Pharma to transfer its OTC business to Mankind Consumer Products

Mankind Pharma has executed the Business Transfer Agreement (BTA) on 03 September 2024 to transfer O

Read more

03 Sept 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

July 2024

PPT

Jan 2024

PPT

June 2023

TranscriptPPT

About Mankind Pharma Ltd

  • Mankind Pharma Limited was incorporated on July 3, 1991, as a Private Limited Company with the name 'Mankind Pharma Private Limited', by the Registrar of Companies, Delhi and Haryana, at New Delhi.
  • Pursuant to conversion of Company to a Public Limited dated July 14, 2005, name of the Company was changed to 'Mankind Pharma Limited' and the RoC issued a fresh Certificate of Incorporation on April 13, 2006. The Company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and chronic therapeutic areas across, as well as several consumer healthcare products.
  • It is present in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins /minerals / nutrients and respiratory.

FAQs for Quarterly Results of Mankind Pharma Ltd

What key financial metrics are included in Mankind Pharma Ltd's quarterly results?

Key financial metrics in Mankind Pharma Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Mankind Pharma Ltd announce its quarterly results?

Mankind Pharma Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Mankind Pharma Ltd's quarterly performance impact its stock price?

Mankind Pharma Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Mankind Pharma Ltd's quarterly results on dividends?

The impact of Mankind Pharma Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Mankind Pharma Ltd's quarterly results?

Yes, Mankind Pharma Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions